Registration Programme Overview Exhibition Virtual Exhibition Satellite Programme Hotel Information VISA Letter Application

 

Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Late onset complications secondary to opaque iris claw intraocular lens implantation for the treatment of intractable diplopia

Poster Details


First Author: A.Ceausescu SPAIN

Co Author(s): M. Mart�nez Hergueta   B. S�nchez Ca�al   N. Domenech Aracil              

Abstract Details

Purpose:

To report late onset complications associated with opaque intraocular lens implantation in a 54 year old female that underwent this procedure for intractable diplopia.

Setting:

Department of Ophthalmology. Hospital General Universitario de Alicante. Alicante. Spain

Methods:

We present the case of a 54-year-old female patient who presented to the Emergency Department with new onset binocular diplopia. Her past ocular history is remarkable for the insertion in the right eye of an opaque iris claw lens with the crystalline lens in situ 20 years ago for intractable diplopia secondary of strabismus. Anterior segment examination reveals intraocular lens subluxation and patent peripheral iridotomy in the right eye. Estimation of the chamber angles was 4/4 via the Von Herrick method. Intraocular pressures were 18 mm Hg in the right eye and 14 mm Hg in the left eye.

Results:

The patient underwent fixation surgery of the subluxated lens and after that she reported complete resolution of diplopia. Postoperatively the patient has persistent corneal oedema due to the law endothelial number of cels- another complication of Artisan iris claw lens in the anterior chamber. Nine months after the surgery the corneal oedema resolved and the endothelial count measured 1045 cells.

Conclusions:

In conclusion, this type of lens represents an efficient option for the treatment of intractable diplopia. However clinicians should be aware and inform the patient appropriately regarding the risk of corneal decompensation and lens subluxation

Financial Disclosure:

None

Back to Poster listing